rs28460440

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_172245.4(CSF2RA):​c.999G>A​(p.Val333Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.399 in 1,611,098 control chromosomes in the GnomAD database, including 130,600 homozygotes. There are 318,614 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. V333V) has been classified as Benign.

Frequency

Genomes: 𝑓 0.37 ( 10490 hom., 26891 hem., cov: 28)
Exomes 𝑓: 0.40 ( 120110 hom. 291723 hem. )

Consequence

CSF2RA
NM_172245.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4O:1

Conservation

PhyloP100: 0.337
Variant links:
Genes affected
CSF2RA (HGNC:2435): (colony stimulating factor 2 receptor subunit alpha) The protein encoded by this gene is the alpha subunit of the heterodimeric receptor for colony stimulating factor 2, a cytokine which controls the production, differentiation, and function of granulocytes and macrophages. The encoded protein is a member of the cytokine family of receptors. This gene is found in the pseudoautosomal region (PAR) of the X and Y chromosomes. Multiple transcript variants encoding different isoforms have been found for this gene, with some of the isoforms being membrane-bound and others being soluble. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant X-1303975-G-A is Benign according to our data. Variant chrX-1303975-G-A is described in ClinVar as [Benign]. Clinvar id is 178717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.337 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF2RANM_172245.4 linkc.999G>A p.Val333Val synonymous_variant Exon 11 of 13 ENST00000381529.9 NP_758448.1 P15509-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF2RAENST00000381529.9 linkc.999G>A p.Val333Val synonymous_variant Exon 11 of 13 1 NM_172245.4 ENSP00000370940.3 P15509-1

Frequencies

GnomAD3 genomes
AF:
0.369
AC:
55455
AN:
150282
Hom.:
10486
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.288
Gnomad AMI
AF:
0.449
Gnomad AMR
AF:
0.333
Gnomad ASJ
AF:
0.381
Gnomad EAS
AF:
0.334
Gnomad SAS
AF:
0.311
Gnomad FIN
AF:
0.444
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.419
Gnomad OTH
AF:
0.385
GnomAD2 exomes
AF:
0.373
AC:
93680
AN:
251110
AF XY:
0.376
show subpopulations
Gnomad AFR exome
AF:
0.283
Gnomad AMR exome
AF:
0.296
Gnomad ASJ exome
AF:
0.367
Gnomad EAS exome
AF:
0.355
Gnomad FIN exome
AF:
0.449
Gnomad NFE exome
AF:
0.412
Gnomad OTH exome
AF:
0.388
GnomAD4 exome
AF:
0.403
AC:
588155
AN:
1460694
Hom.:
120110
Cov.:
48
AF XY:
0.402
AC XY:
291723
AN XY:
726492
show subpopulations
Gnomad4 AFR exome
AF:
0.285
AC:
9530
AN:
33446
Gnomad4 AMR exome
AF:
0.303
AC:
13536
AN:
44712
Gnomad4 ASJ exome
AF:
0.373
AC:
9734
AN:
26106
Gnomad4 EAS exome
AF:
0.295
AC:
11690
AN:
39692
Gnomad4 SAS exome
AF:
0.328
AC:
28264
AN:
86214
Gnomad4 FIN exome
AF:
0.438
AC:
23411
AN:
53406
Gnomad4 NFE exome
AF:
0.419
AC:
466032
AN:
1111022
Gnomad4 Remaining exome
AF:
0.393
AC:
23715
AN:
60338
Heterozygous variant carriers
0
19582
39164
58745
78327
97909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
14142
28284
42426
56568
70710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.369
AC:
55464
AN:
150404
Hom.:
10490
Cov.:
28
AF XY:
0.367
AC XY:
26891
AN XY:
73284
show subpopulations
Gnomad4 AFR
AF:
0.287
AC:
0.287256
AN:
0.287256
Gnomad4 AMR
AF:
0.333
AC:
0.332912
AN:
0.332912
Gnomad4 ASJ
AF:
0.381
AC:
0.380939
AN:
0.380939
Gnomad4 EAS
AF:
0.334
AC:
0.333731
AN:
0.333731
Gnomad4 SAS
AF:
0.312
AC:
0.311631
AN:
0.311631
Gnomad4 FIN
AF:
0.444
AC:
0.444026
AN:
0.444026
Gnomad4 NFE
AF:
0.419
AC:
0.419012
AN:
0.419012
Gnomad4 OTH
AF:
0.382
AC:
0.381528
AN:
0.381528
Heterozygous variant carriers
0
1403
2806
4209
5612
7015
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
552
1104
1656
2208
2760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Bravo
AF:
0.362
EpiCase
AF:
0.425
EpiControl
AF:
0.426

ClinVar

Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:1
Dec 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Val333Val in exon 12 of CSF2RA: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 43.0% (3695/8592) of European American chromosomes from a broad population by the NHLBI Exome Sequ encing Project (http://evs.gs.washington.edu/EVS; dbSNP rs146020675). -

Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.64
DANN
Benign
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28460440; hg19: chrX-1422868; COSMIC: COSV62625891; COSMIC: COSV62625891; API